How Does CBD Work For Multiple Sclerosis Spasticity?
One of the more recent trends in the world of cannabis has been an explosion of growth in the area of CBD. Ten years ago, the substance wasn’t even legal in most of the world. Now, it’s legal in dozens of countries, such as the United States. As a result of this changing legal scene, the popularity of CBD has exploded, and it is expected to generate as much as $22 billion over the next three years.
CBD is popular because there is some evidence – also experienced by millions of users – which shows that CBD can help a slew of emotional and physical problems. Ongoing research has demonstrated that CBD has the potential to alleviate the symptoms of a variety of illnesses. One such example is reducing Multiple Sclerosis Spasticity.
How CBD Can Help Multiple Sclerosis Spasticity
Spasticity is one of the many debilitating symptoms of Multiple Sclerosis. It is characterized by uncontrollable muscle spasms which can make limbs difficult to move. CBD may be able to help reduce or control spasticity; however, it cannot “cure” Multiple Sclerosis.
In general, CBD works by altering the interactions of your body’s Endocannabinoid System, or ECS. The ECS consists of naturally produced cannabinoids the cannabinoid receptors. Researchers have identified two receptors, CB1 and CB2. These receptors are found throughout the body.
It is theorized that CBD helps control spasticity by altering the interactions between cannabinoids and CB1/CB2. The ECS is believed to be involved in synaptic neurotransmission which impacts muscle spasms. As such, CBD may help to regulate muscle spasticity. Indeed, in many countries where medical-grade CBD or marijuana is legal, one of the most common accepted treatments for spasticity associated with Multiple Sclerosis.
Studies On CBD And Multiple Sclerosis Spasticity
Numerous studies have shown that CBD has the potential to reduce spasticity, with some research going back as far as a survey from 1982. Indeed, within the realm of CBD, Multiple Sclerosis seems to be one of the more studied disorders. A 2008 review of available literature identified numerous studies which found that CBD and THC could reduce spasticity. A 2012 review found that Sativex, a THC/CBD drug, could be extremely effective in reducing the worst symptoms of Multiple Sclerosis, including spasticity.
Another study, released in 2018, found that CBD could improve mobility and reduce spasticity. Most recently, research presented at the 2019 American Academy of Neurology Annual Meeting showed that THC and CBD medication could reduce spasticity – particularly when the spasticity was resistant to other medication.
As noted by many organizations and researchers, more study is needed. Therapeutic doses are currently unknown, and CBD may interact with other drugs or disorders, setting up potential problems for individuals. Furthermore, it is not currently known what strains are most effective.
However, initial research does show promise and future research may indicate how CBD can assist patients who suffer from Multiple Sclerosis Spasticity.